Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock?

Group 1 - The stock of Krystal Biotech, Inc. (KRYS) is experiencing significant attention due to high implied volatility in the options market, particularly for the Feb. 21, 2025 $100 Call option [1] - Implied volatility indicates the market's expectation of future price movement, suggesting that investors anticipate a significant change in the stock's price, potentially due to an upcoming event [2] - Krystal Biotech currently holds a Zacks Rank 4 (Hold) in the Medical - Biomedical and Genetics industry, which is in the top 31% of the Zacks Industry Rank, with no changes in earnings estimates from analysts over the last 60 days [3] Group 2 - The high implied volatility surrounding Krystal Biotech may indicate a developing trading opportunity, as options traders often seek to sell premium on such options to capture decay, hoping the stock does not move as much as expected by expiration [4]